JP6814239B2 - Ventilation layer - Google Patents
Ventilation layer Download PDFInfo
- Publication number
- JP6814239B2 JP6814239B2 JP2019039635A JP2019039635A JP6814239B2 JP 6814239 B2 JP6814239 B2 JP 6814239B2 JP 2019039635 A JP2019039635 A JP 2019039635A JP 2019039635 A JP2019039635 A JP 2019039635A JP 6814239 B2 JP6814239 B2 JP 6814239B2
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- ventilation layer
- solid
- peroxide
- hydroxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000009423 ventilation Methods 0.000 title claims description 32
- 239000001257 hydrogen Substances 0.000 claims description 115
- 229910052739 hydrogen Inorganic materials 0.000 claims description 115
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 110
- 239000000203 mixture Substances 0.000 claims description 47
- 239000000463 material Substances 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 21
- 238000004519 manufacturing process Methods 0.000 claims description 20
- 239000007787 solid Substances 0.000 claims description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 229910000000 metal hydroxide Inorganic materials 0.000 claims description 13
- 150000004692 metal hydroxides Chemical class 0.000 claims description 13
- 239000011973 solid acid Substances 0.000 claims description 13
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 10
- 150000004972 metal peroxides Chemical class 0.000 claims description 10
- 239000001301 oxygen Substances 0.000 claims description 10
- 229910052760 oxygen Inorganic materials 0.000 claims description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- XXQBEVHPUKOQEO-UHFFFAOYSA-N potassium superoxide Chemical compound [K+].[K+].[O-][O-] XXQBEVHPUKOQEO-UHFFFAOYSA-N 0.000 claims description 8
- -1 polypropylene Polymers 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 239000004033 plastic Substances 0.000 claims description 6
- 229920003023 plastic Polymers 0.000 claims description 6
- 239000010408 film Substances 0.000 claims description 5
- 239000004343 Calcium peroxide Substances 0.000 claims description 4
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 4
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 claims description 4
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 4
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 4
- 239000000920 calcium hydroxide Substances 0.000 claims description 4
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 4
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 claims description 4
- 235000019402 calcium peroxide Nutrition 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 claims description 4
- 239000000347 magnesium hydroxide Substances 0.000 claims description 4
- 229910001862 magnesium hydroxide Inorganic materials 0.000 claims description 4
- 229960004995 magnesium peroxide Drugs 0.000 claims description 4
- 235000006408 oxalic acid Nutrition 0.000 claims description 4
- 235000002949 phytic acid Nutrition 0.000 claims description 4
- 239000000467 phytic acid Substances 0.000 claims description 4
- 229940068041 phytic acid Drugs 0.000 claims description 4
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 claims description 4
- 229920000247 superabsorbent polymer Polymers 0.000 claims description 4
- 239000004698 Polyethylene Substances 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 208000014617 hemorrhoid Diseases 0.000 claims description 3
- 239000004745 nonwoven fabric Substances 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 3
- 239000008188 pellet Substances 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 claims description 3
- 235000012239 silicon dioxide Nutrition 0.000 claims description 3
- 239000010409 thin film Substances 0.000 claims description 3
- 239000003642 reactive oxygen metabolite Substances 0.000 claims description 2
- 239000010410 layer Substances 0.000 description 48
- 230000000694 effects Effects 0.000 description 32
- 210000001508 eye Anatomy 0.000 description 16
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 210000000214 mouth Anatomy 0.000 description 13
- 208000027418 Wounds and injury Diseases 0.000 description 12
- 206010052428 Wound Diseases 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 11
- 150000002978 peroxides Chemical group 0.000 description 11
- 239000007789 gas Substances 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 208000012902 Nervous system disease Diseases 0.000 description 5
- 208000025966 Neurological disease Diseases 0.000 description 5
- 239000006227 byproduct Substances 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 238000001959 radiotherapy Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 150000002431 hydrogen Chemical class 0.000 description 4
- 229910052987 metal hydride Inorganic materials 0.000 description 4
- 150000004681 metal hydrides Chemical class 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000019606 astringent taste Nutrition 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 230000008821 health effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 description 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229910004283 SiO 4 Inorganic materials 0.000 description 2
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229960002949 fluorouracil Drugs 0.000 description 2
- 150000004679 hydroxides Chemical class 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229910012375 magnesium hydride Inorganic materials 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 229910052700 potassium Chemical group 0.000 description 2
- 239000011591 potassium Chemical group 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 229910052990 silicon hydride Inorganic materials 0.000 description 2
- 239000011863 silicon-based powder Substances 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 208000030090 Acute Disease Diseases 0.000 description 1
- 229910017090 AlO 2 Inorganic materials 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000002424 anti-apoptotic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000011777 magnesium Chemical group 0.000 description 1
- 229910052749 magnesium Chemical group 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
- Y02E60/30—Hydrogen technology
- Y02E60/36—Hydrogen production from non-carbon containing sources, e.g. by water electrolysis
Landscapes
- Respiratory Apparatuses And Protective Means (AREA)
- Corsets Or Brassieres (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は、水素生成組成物を含む通気層を提供する。本発明は、水素が刺激性を有さないこと、優れた拡散力を有すること、および反応が有害な副産物を生成しないことなどの利点から、皮膚や人体内部に水素を供給することで、保健、疾患改善の用途を達成する、生活保健領域に属する。 The present invention provides an aerated layer containing a hydrogen-producing composition. The present invention provides health by supplying hydrogen to the skin and the inside of the human body because of the advantages that hydrogen is not irritating, has excellent diffusivity, and the reaction does not produce harmful by-products. , Achieves the use of disease improvement, belongs to the area of living health.
水素(H2)は無色無味のガスであり、1975年の研究報道によると、水素は、酸化防止ガスとしてガンを治療することができる。2007年に日本の学者が水素で有毒なラジカルを中和し、脳虚血を治療して損傷を灌流した。その後の大量の研究では、水素は多くの病気や損傷に治療効果があると確認されている。水素は、生物酸化防止物質として、選択的にラジカルを中和でき、酸化防止、炎症防止およびアポトーシス抑制などの効果があり、体内に生理作用を持つ活性酸素に影響することはない。例えば、スーパーオキシドアニオン和過酸化水素などは、水素が安全に人体に使用できることを説明する。水素のもう一つの利点は、強い拡散力を持つこと、細胞膜と各生物バリアが水素の拡散浸透に影響せず、身体のどの部位にも届くことから、卒中、糖尿病、動脈硬化症、パーキンソン病などのよくある急性と慢性の疾患に治療作用があると考えられる。 Hydrogen (H 2 ) is a colorless and tasteless gas, and according to research reports in 1975, hydrogen can treat cancer as an antioxidant gas. In 2007, Japanese scholars neutralized toxic radicals with hydrogen to treat cerebral ischemia and perfuse the damage. Subsequent extensive studies have confirmed that hydrogen has a therapeutic effect on many illnesses and injuries. As a biological antioxidant, hydrogen can selectively neutralize radicals, has antioxidative, anti-inflammatory and anti-apoptotic effects, and does not affect active oxygen, which has a physiological effect in the body. For example, superoxide anion hydrogen peroxide and the like explain that hydrogen can be safely used in the human body. Another advantage of hydrogen is that it has a strong diffusive power, and because the cell membrane and each biological barrier do not affect the diffusion and penetration of hydrogen and reach any part of the body, stroke, diabetes, arteriosclerosis, Parkinson's disease. It is considered to have a therapeutic effect on common acute and chronic diseases such as.
水素の使用としては、水素を吸入すること、水素水を飲むこと、または水素塩水を注射することなどの方法がある。水素を吸入することは、卒中、心筋梗塞などの神経、心血管疾患に改善作用がある。水素水を飲むことは、糖尿病と代謝病に治療効果があると報道されている。一方、動物モデルでは、水素水を飲むことは、アレルギー性疾患を改善できると証明されている。例えば、アトピー性湿疹、および、網膜症の眼球に直接注射することで眼底疾患を治療できる。日本の鹿児島大学とインドネシアのSam Ratulangi大学が協力して、高濃度の水素水を採用し、抗がん剤5−フルオロウラシルと合わせて使用し、細胞学と動物モデルの2パータンを利用した結果、水素が腫瘍のアポトーシスを促進するだけでなく、明らかに5−フルオロウラシルの抗腫瘍効果を増やすことができ、腫瘍を患う動物の寿命を延ばすことが証明されている。 The use of hydrogen includes methods such as inhaling hydrogen, drinking hydrogen water, or injecting hydrogen salt water. Inhalation of hydrogen has an improving effect on neurological and cardiovascular diseases such as stroke and myocardial infarction. Drinking hydrogen water has been reported to have therapeutic effects on diabetes and metabolic diseases. On the other hand, in animal models, drinking hydrogen water has been shown to improve allergic diseases. For example, atopic eczema and fundus disease can be treated by direct injection into the eyeball of retinopathy. As a result of cooperation between Kagoshima University in Japan and Sam Ratulangi University in Indonesia, high-concentration hydrogen water was adopted, used in combination with the anticancer drug 5-fluorouracil, and two patterns of cytology and animal model were used. It has been demonstrated that hydrogen not only promotes tumor apoptosis, but can also clearly increase the antitumor effect of 5-fluorouracil, prolonging the lifespan of tumor-affected animals.
現在のよくある水素供給方法は、水素水や高圧水素タンクを含む。水素水は、水素を水の中で融合させる。最初の水素製造機は、体積が大きく、電力も必要であり、さらに製作した水素水は保存しづらく、高純度な水素を補充する場合には、通常高圧水素タンクを使用した。体積、重量がもたらした携帯の不便さの問題以外に、高圧気体タンクが潜在的な安全リスクを持つため、使用上に懸念があった。水素製造機と高圧水素タンクが携帯しづらいため、広めるのが容易ではなく、水素の実際の応用に制限がかかった。故に、いつでもどこでも、使用しやすい水素をどのように供給するのかが本発明の解決する課題である。 Current common hydrogen supply methods include hydrogen water and high pressure hydrogen tanks. Hydrogen water fuses hydrogen in water. The first hydrogen maker had a large volume and required electric power, and the produced hydrogen water was difficult to store. When replenishing high-purity hydrogen, a high-pressure hydrogen tank was usually used. In addition to the inconvenience of carrying due to volume and weight, there were concerns about its use due to the potential safety risks of high pressure gas tanks. Since the hydrogen maker and the high-pressure hydrogen tank are difficult to carry, it is not easy to spread and the actual application of hydrogen is limited. Therefore, how to supply easy-to-use hydrogen anytime, anywhere is a problem to be solved by the present invention.
市場には、皮膚に触れる様々な生活衛生材料(口マスク、顔マスク、パックなど)がある。皮膚に直接接触するため、よく履き心地と便利さが宣伝される。しかし、近年、当業者も他の合併および達成できる効果について、改良と突破を求めている。例えば、内部材料の反応によって、人体に酸素などの有益なガスを供給することである。しかし、ガスの供給は、材料間の内部化学作用によるものであるため、保健効果を向上させるためには、常にさらに多くの材料を含み、また、同時にさらに多くの種類の材料の組み合わせを含むことが必要であり、材料漏れまたは不安全な副産物のリスクが発生する。 There are various skin-touching living hygiene materials on the market (mouth masks, face masks, facial masks, etc.). Because it comes into direct contact with the skin, it is often advertised for comfort and convenience. However, in recent years, those skilled in the art have also sought improvements and breakthroughs in other mergers and achievable effects. For example, the reaction of internal materials supplies the human body with beneficial gases such as oxygen. However, since the gas supply is due to internal chemistry between the materials, it should always contain more materials and at the same time include more types of material combinations in order to improve the health effect. Is required and there is a risk of material leakage or unsafe by-products.
したがって、生活衛生材料中に水素を供給できる通気層を提供することが、本発明が解決しようとする重要な課題である。 Therefore, providing a ventilation layer capable of supplying hydrogen into the living hygiene material is an important problem to be solved by the present invention.
前記の課題を解決するために、本願の発明人は、薄層及び水素生成組成物を含む、水素を供給する通気層を提供する。当該薄層の外側は通気せず、内側は通気し、内側の表面には複数の小さい孔がある。当該薄層は、単層または多層である。そして、水素生成組成物は、当該薄層中に含まれ、漏れることなく空気中の水分または液体の水を吸収して水素を生成する。当該水素は、当該複数の小さい孔を通過して皮膚および人体内部に排出される。 To solve the above problems, the inventor of the present application provides a hydrogen-supplying aeration layer containing a thin layer and a hydrogen-producing composition. The outside of the thin layer is not ventilated, the inside is ventilated, and the inner surface has a number of small holes. The thin layer is a single layer or a multi-layer. Then, the hydrogen-producing composition is contained in the thin layer and absorbs water in the air or liquid water without leaking to generate hydrogen. The hydrogen passes through the plurality of small holes and is discharged into the skin and the inside of the human body.
本願発明の目的を達成するために、当該薄層の内側の材質は、シリカゲル、不織布、またはプラスチック通気膜であってもよい。 In order to achieve the object of the present invention, the material inside the thin layer may be silica gel, non-woven fabric, or plastic breathable membrane.
本願発明の目的を達成するために、当該薄層の外側の材質は、ポリプロピレン、ポリエチレンプラスチック薄膜、アルミニウム膜、または複合膜であってもよい。 In order to achieve the object of the present invention, the outer material of the thin layer may be polypropylene, a polyethylene plastic thin film, an aluminum film, or a composite film.
本願発明の目的を達成するために、当該水素生成組成物は、粉末状、またはペレット状であってもよい。 In order to achieve the object of the present invention, the hydrogen producing composition may be in the form of powder or pellets.
本願発明の目的を達成するために、当該水素生成組成物は、金属過酸化物、金属水酸化物または金属水素化物、および、アルミニウム粉末またはケイ素粉末を含む。 To achieve the object of the present invention, the hydrogen producing composition comprises a metal peroxide, a metal hydroxide or a metal hydride, and an aluminum powder or a silicon powder.
本願発明の目的を達成するために、当該水素生成組成物の重量割合は、金属過酸化物または金属水酸化物:アルミニウム粉末=1:100−100:1、好ましくは1:10−10:1であってもよい。 In order to achieve the object of the present invention, the weight ratio of the hydrogen generation composition is metal peroxide or metal hydroxide: aluminum powder = 1: 100-100: 1, preferably 1:10-10: 1. It may be.
本願発明の目的を達成するために、当該金属過酸化物は、過酸化カルシウム、過酸化マグネシウム、過酸化ナトリウム、および過酸化カリウムからなる群より選択される。当該金属水酸化物は、水酸化カルシウム、水酸化マグネシウム、水酸化ナトリウム、および水酸化カリウムからなる群より選択される。当該金属水素化物は、水素化マグネシウム、水素化カルシウム、および水素化ケイ素からなる群より選択される。 In order to achieve the object of the present invention, the metal peroxide is selected from the group consisting of calcium peroxide, magnesium peroxide, sodium peroxide, and potassium peroxide. The metal hydroxide is selected from the group consisting of calcium hydroxide, magnesium hydroxide, sodium hydroxide, and potassium hydroxide. The metal hydride is selected from the group consisting of magnesium hydride, calcium hydride, and silicon hydride.
本願発明の目的を達成するために、当該水素生成組成物に固体酸が添加される。当該固体酸は、固体クエン酸、固体乳酸、固体シュウ酸、固体塩酸、固体フィチン酸および固体ケイ酸からなる群より選択される。 In order to achieve the object of the present invention, a solid acid is added to the hydrogen producing composition. The solid acid is selected from the group consisting of solid citric acid, solid lactic acid, solid oxalic acid, solid hydrochloric acid, solid phytic acid and solid silicic acid.
本願発明の目的を達成するために、当該水素生成組成物は、さらに、高吸水性ポリマー、活性劑または触媒を含むことができる。 In order to achieve the object of the present invention, the hydrogen producing composition may further contain a superabsorbent polymer, an activator or a catalyst.
本願発明の目的を達成するために、当該薄層は、さらに、酸素および活性酸素生成単位を含むことができる。 To achieve the object of the present invention, the thin layer may further contain oxygen and reactive oxygen species producing units.
本願発明の目的を達成するために、当該通気層は、生活衛生材料中に使用できる。当該生活衛生材料は、アイマスク、口マスク、顔マスク、パック、ブラジャー、ニプレス、胸部パッド、ナプキン、紙おむつ、サニタリーパッド、創傷被覆材、絆創膏、ガーゼ、痔疾用パッドを含む。 In order to achieve the object of the present invention, the ventilation layer can be used in a living hygiene material. The living hygiene materials include eye masks, mouth masks, face masks, packs, bras, pasties, chest pads, napkins, paper diapers, sanitary pads, wound dressings, adhesive plasters, gauze, and hemorrhoid pads.
本発明は、水素生成組成物を含む通気層に関し、短時間で、大量の水素を生成して、人体の皮膚、鼻孔、口腔、目、または他の触れる人体部位に供給できる。本発明の有利な効果は以下の通りである。
(1) 安全かつ、便利に使用できる。
タンクパイプラインやプラグインは必要ない。携帯しやすく、組成物は無害で、体に触れた状態で使用できる。
(2) 有害な副産物を生成しない
(3) 皮膚に近いため、吸収されやすい。
(4) 水素の幅広い身体保健用途を提供する。
−優れた拡散力を有し、届く部位に制限がない。
−無毒で、人体に優しい安全な還元剤である。
−優れた酸化防止、抗炎症効果を有する。
−常在菌を改善する。
The present invention relates to an aerated layer containing a hydrogen producing composition, which can generate a large amount of hydrogen in a short time and supply it to the skin, nostrils, oral cavity, eyes, or other touching human body parts of the human body. The advantageous effects of the present invention are as follows.
(1) Safe and convenient to use.
No tank pipeline or plugin required. It is easy to carry, the composition is harmless, and it can be used in contact with the body.
(2) Do not produce harmful by-products
(3) Since it is close to the skin, it is easily absorbed.
(4) Provide a wide range of physical health uses for hydrogen.
-Has excellent diffusive power and has no restrictions on the reachable area.
-A non-toxic, safe reducing agent that is gentle on the human body.
-Has excellent antioxidant and anti-inflammatory effects.
-Improves indigenous bacteria.
通気層の最も好ましい保健効果を得るために、本発明は、さらに、必要かつ最適な水素生成組成物の割合と投薬量を示し、通気層が生活衛生材料中に用いられること、及び本発明の応用を例示する。 In order to obtain the most favorable health effects of the aerated layer, the present invention further indicates the necessary and optimal proportion and dosage of the hydrogen-producing composition, the aerated layer is used in the living hygiene material, and the present invention. Illustrate the application.
以下の実施例に示すように、本発明を説明するが、本発明は下記の実施例に限定されるものではない。以下、具体的に、本願の水素を供給する通気層が含む特徴、応用と利点を説明するが、本発明の技術精神を逸脱しない同等な実施または変更であれば、いずれも本願の特許請求の範囲の中に含まれる。 The present invention will be described as shown in the following examples, but the present invention is not limited to the following examples. Hereinafter, the features, applications and advantages contained in the hydrogen-supplying ventilation layer of the present application will be specifically described, but any equivalent implementation or modification that does not deviate from the technical spirit of the present invention is claimed in the present application. Included in the range.
図1−図3に示すように、本発明は、水素生成組成物が含まれる薄層11、及び、薄層11を含む通気層1を提供する。当該薄層11の外側は通気せず、内側は通気し、内側の表面には複数の小さい孔がある。当該薄層は、単層または多層であってもよい。そして、水素生成組成物12は、当該薄層11中に含まれ、漏れることなく空気中の水分または液体の水を吸収して水素を生成する。図2に示されるように、当該水素は当該複数の小さい孔111を通過し、皮膚、鼻孔、口腔、目、その他の触れている人体部位を経由して、人体内部に吸収される。
As shown in FIGS. 1 to 3, the present invention provides a
本発明は、外側が通気せず、内側が通気する当該薄層11で水素生成組成物12を覆う。当該水素生成組成物12が漏れないようにするため、当該薄層の内側の小さい孔111の孔径は当該水素生成組成物12の直径より小さい。当該薄層11の外側は通気しない材質で形成され、内側は皮膚に優しい材質で形成されている。
In the present invention, the
保存に際しては、空気中の水分が先に当該水素生成組成物12と反応しないようにするため、密閉材料で包装する。使用時には密閉包装を剥がし、必要な位置に適用する。当該通気層1を使用することで、外側の通気しない材質によって、汗水、湿気等の水分をカットすることができ、水分が漏れない。したがって、充分に、当該水素生成組成物12を反応させて、皮膚に対し水素を供給できる。
At the time of storage, it is wrapped in a closed material so that the moisture in the air does not react with the
当該水素生成組成物12を覆うために使用する当該薄層11の内側の材質は、シリカゲル、不織布、またはプラスチック通気膜であってもよい。当該薄層11の外側の材質は、ポリプロピレン、ポリエチレンプラスチック薄膜、アルミニウム膜または複合膜であってもよい。
The material inside the
当該水素生成組成物12は、粉末状、ペレット状であってもよい。そして、当該水素生成組成物12は、金属過酸化物、金属水酸化物または金属水素化物、および、アルミニウム粉またはケイ素粉末を含む。
The
中でも、当該金属過酸化物は、過酸化カルシウム、過酸化マグネシウム、過酸化ナトリウム、および過酸化カリウムからなる群より選択される。当該金属水酸化物は、水酸化カルシウム、水酸化マグネシウム、水酸化ナトリウム、および水酸化カリウムからなる群より選択される。 Among them, the metal peroxide is selected from the group consisting of calcium peroxide, magnesium peroxide, sodium peroxide, and potassium peroxide. The metal hydroxide is selected from the group consisting of calcium hydroxide, magnesium hydroxide, sodium hydroxide, and potassium hydroxide.
当該水素生成組成物は、さらに、水分で金属水酸化物を生成できる化合物を含んでもよい。そのような化合物は、例えば、水素化マグネシウム、水素化カルシウム、および水素化ケイ素である。 The hydrogen-producing composition may further contain a compound capable of forming a metal hydroxide with water. Such compounds are, for example, magnesium hydride, calcium hydride, and silicon hydride.
当該水素生成組成物は、選択的に固体酸を添加し、前記水素生成組成物と中和作用を起こして、pH値を4−9の間にすることで、皮膚を刺激するのを避け、水素の吸収効果を向上させることができる。当該固体酸は、固体クエン酸、固体乳酸、固体シュウ酸、固体塩酸、固体フィチン酸および固体ケイ酸からなる群より選択される。 The hydrogen-producing composition selectively adds a solid acid to neutralize the hydrogen-producing composition to bring the pH value between 4-9, thereby avoiding irritation to the skin. The hydrogen absorption effect can be improved. The solid acid is selected from the group consisting of solid citric acid, solid lactic acid, solid oxalic acid, solid hydrochloric acid, solid phytic acid and solid silicic acid.
以下の反応式は、水素生成組成物が水素を供給するメカニズムを表す。
過酸化物であれば、最初は水と反応することで、水酸化物を生成し、酸素を排出する。反応式は以下の通りである。
The following reaction formula represents the mechanism by which the hydrogen production composition supplies hydrogen.
If it is a peroxide, it first reacts with water to generate a hydroxide and discharge oxygen. The reaction formula is as follows.
2XO2+2H2O→2X(OH)2+O2(Xはカルシウム、マグネシウムである) または、
2Y2O2+2H2O→4Y(OH)+O2(Yはナトリウム、カリウムである)
2XO 2 + 2H 2 O → 2X (OH) 2 + O 2 (X is calcium and magnesium) or
2Y 2 O 2 + 2H 2 O → 4Y (OH) + O 2 (Y is sodium and potassium)
水酸化物はアルミニウム粉末と反応でき、水素を生成する。以下の反応式を参照のこと。
2Al+2H2O+X(OH)2=X(AlO2)2+3H2
2Al+2H2O+2Y(OH)=2YAlO2+3H2
Hydroxides can react with aluminum powder to produce hydrogen. See the reaction equation below.
2Al + 2H 2 O + X (OH) 2 = X (AlO 2 ) 2 + 3H 2
2Al + 2H 2 O + 2Y (OH) = 2YAlO 2 + 3H 2
金属水素化物は、水分と反応することで、水素および金属水酸化物を生成する。金属水酸化物は再び水と反応し、水素を生成し続ける。 Metal hydrides react with water to produce hydrogen and metal hydroxides. The metal hydroxide reacts with water again and continues to produce hydrogen.
前記の反応で、より早く大量の水素を生成しようとすると、反応物として活性の大きいアルカリ金属(IA族)(即ち、ナトリウム或カリウム)の過酸化物または水酸化物を選択できる。 If a large amount of hydrogen is to be produced faster in the above reaction, a peroxide or hydroxide of a highly active alkali metal (Group IA) (that is, sodium or potassium) can be selected as the reactant.
上に例示される水素生成組成物の組み合わせの応用で、当該業界において通常の技術を持つ者もケイ素と水酸化物及び水とを反応させることで、水素が生成するという応用を連想できる。これは本願の組み合わせの同等な実施、本願の水素生成組成物の特許請求の範囲内に含まれるべきであり、その反応式は以下である。 In the application of the combination of hydrogen production compositions exemplified above, a person having ordinary technology in the industry can also associate the application that hydrogen is generated by reacting silicon with hydroxide and water. This should be within the scope of the equivalent implementation of the combination of the present application, the claims of the hydrogen production composition of the present application, the reaction formula of which is:
Si+4H2O=H4SiO4+2H2
H4SiO4+2NaOH=Na2SiO3+3H2
Si + 4H 2 O = H 4 SiO 4 + 2H 2
H 4 SiO 4 + 2 NaOH = Na 2 SiO 3 + 3H 2
好ましい投薬量の割合をはっきりさせるため、各反応物がそれぞれ0.01−100gの範囲のときの水素生成効率を測定する。前記水素生成組成物は、重量割合で、金属過酸化物または金属水酸化物:アルミニウム粉=1:100−100:1のとき、反応して水素を生成する。前記重量割合が1:10−10:1のとき、最も好ましい水素生成効率が達成される。 To determine the preferred dosage ratio, hydrogen production efficiency is measured when each reactant is in the range of 0.01-100 g. The hydrogen production composition reacts to generate hydrogen when the ratio of metal peroxide or metal hydroxide: aluminum powder = 1: 100-100: 1. When the weight ratio is 1:10-10: 1, the most preferable hydrogen production efficiency is achieved.
当該通気膜は、生活衛生材料に応用され、体に触れた状態で使用できる。当該生活衛生材料は、アイマスク(図4)、口マスク(図5A、図5B)、顔マスク、パック(図6)、ブラジャー、ニプレス、胸部パッド、ナプキン、紙おむつ、サニタリーパッド、創傷被覆材(図7)、絆創膏、ガーゼ、痔疾用パッドを含むが、それらに限らない。 The breathable membrane is applied to a living hygiene material and can be used in contact with the body. The living hygiene materials include eye masks (Fig. 4), mouth masks (Fig. 5A, Fig. 5B), face masks, packs (Fig. 6), brassieres, pasties, chest pads, napkins, paper diapers, sanitary pads, and wound dressings. Figure 7), including, but not limited to, adhesive plasters, gauze, and hemorrhoid pads.
以下、あらゆる関係する疾患、症状(中には、神経疾患、最近放射線治療をした者、便秘、紫外線損傷、目の渋み、目のつらさ、外傷を含む。)を持つ試験者を集め、当該通気膜の口マスク、アイマスク、パック、または創傷被覆材などを含む生活衛生材料を配り、使用してもらった。三ヶ月間持続的に使用、週に三回、一回に二時間使用した後にアンケートに答えてもらい、当該通気層の水素生成組成物を様々な生活衛生材料に応用した時の各疾患、症状の改善効果およびその使用上の履き心地について調べた(1−10を評価基準として、大きいほど効果が高い。)。同時に、市販のガス発生材料を含まない一般的な製品(以下、市販と略称する)、および、アルミニウム粉末を含まない(水素が発生しない)製品と比べた。各評価統計の平均結果を以下に示す。当該通気膜中の水素生成組成物は、上記の好ましい割合(金属過酸化物または金属水酸化物:アルミニウム粉=100:80−120)であり、対応する生活衛生材料によって、含有量を調整した。 The following is a collection of testers with all related diseases and symptoms (including neurological disorders, recent radiation therapy, constipation, UV damage, astringency of the eyes, eye tightness, trauma) and the ventilation. Living hygiene materials, including membrane mouth masks, eye masks, packs, or wound coverings, were distributed and used. Continuous use for 3 months, 3 times a week, 2 hours at a time, then answer the questionnaire, and apply the hydrogen generation composition of the ventilation layer to various living hygiene materials. The improvement effect of the above and the comfort of its use were investigated (using 1-10 as an evaluation standard, the larger the value, the higher the effect). At the same time, it was compared with a general product that does not contain a commercially available gas generating material (hereinafter abbreviated as commercially available) and a product that does not contain aluminum powder (does not generate hydrogen). The average result of each evaluation statistic is shown below. The hydrogen-producing composition in the air-permeable membrane had the above-mentioned preferable ratio (metal peroxide or metal hydroxide: aluminum powder = 100: 80-120), and the content was adjusted according to the corresponding living hygiene material. ..
実施例一、口マスク Example 1, mouth mask
試験の組及び結果を表1に示す。過酸化物は過酸化カルシウムであり、水酸化物は水酸化カルシウムであり、いずれも10gである。アルミニウム粉末は1gであり、クエン酸は適量である。皮膚の水分または追加した水によって、水素を生成した。 Table 1 shows the test sets and results. The peroxide is calcium peroxide, and the hydroxide is calcium hydroxide, both of which weigh 10 g. The amount of aluminum powder is 1 g, and the amount of citric acid is appropriate. Hydrogen was produced by skin moisture or added water.
結果では、本願の水素生成組成物は、神経疾患、放射性療法の副作用、便秘などの疾患/症状を改善できることが示された。これらの効果は、市販の口マスクでも、酸素だけを生成する(アルミニウム粉末を含まない)組でも、達成できない。また、本願の各組み合わせの履き心地は、いずれの市販の口マスクよりいい。そして、同時に過酸化物、水酸化物、固体酸を有する場合は、より最も好ましい疾患の改善効果及び履き心地を達成できた。 The results showed that the hydrogen-producing composition of the present application can improve diseases / symptoms such as neurological diseases, side effects of radiotherapy, and constipation. These effects cannot be achieved with either commercially available mouth masks or pairs that produce only oxygen (without aluminum powder). In addition, the comfort of each combination of the present application is better than that of any commercially available mouth mask. And, when having a peroxide, a hydroxide, and a solid acid at the same time, a more preferable effect of improving the disease and comfort could be achieved.
表1−口マスクにおける通気層の各疾患、症状についての改善効果及び履き心地 Table 1-Improvement effect and comfort of each disease and symptom of the ventilation layer in the mouth mask
実施例二、アイマスク Example 2, eye mask
試験の組及び結果を表2に示す。過酸化物は過酸化ナトリウムであり、水酸化物は水酸化ナトリウムであり、いずれも1gである。アルミニウム粉末は10gであり、シュウ酸は適量である。追加した水によって、水素を生成した。 Table 2 shows the test sets and results. The peroxide is sodium peroxide and the hydroxide is sodium hydroxide, both of which weigh 1 g. The amount of aluminum powder is 10 g, and the amount of oxalic acid is appropriate. Hydrogen was produced by the added water.
結果では、本願の水素生成組成物は、目の渋み、目の疾患を改善できることが示された。市販のアイマスク、または、アルミニウム粉末を含まない(水素を生成できない)組と比べ、いずれもよりよい効果を有している。また、本願の各組み合わせの履き心地は、いずれの市販のアイマスクよりいい。そして、同時に過酸化物、水酸化物、固体酸を有する場合は、より最も好ましい効果及び履き心地を達成できた。 The results showed that the hydrogen-producing composition of the present application can improve eye astringency and eye diseases. Both have better effects than commercially available eye masks or sets that do not contain aluminum powder (cannot generate hydrogen). In addition, the comfort of each combination of the present application is better than that of any commercially available eye mask. And, when having a peroxide, a hydroxide, and a solid acid at the same time, the most preferable effect and comfort could be achieved.
表2−アイマスクにおける通気層の各疾患、症状についての改善効果および履き心地 Table 2-Improvement effect and comfort of each disease and symptom of the ventilation layer in the eye mask
実施例三、パック Example 3, pack
試験の組及び結果を表3に示す。過酸化物は過酸化マグネシウムであり、水酸化物は水酸化マグネシウムであり、いずれも12.5gである。アルミニウム粉末は6.25gであり、固体酸である乳酸は適量である。追加した水によって、水素を生成した。 Table 3 shows the test sets and results. The peroxide is magnesium peroxide, and the hydroxide is magnesium hydroxide, both of which weigh 12.5 g. The amount of aluminum powder is 6.25 g, and the amount of lactic acid, which is a solid acid, is appropriate. Hydrogen was produced by the added water.
結果では、市販のパック、または、アルミニウム粉末を含まない(水素を生成できない)組と比べ、本願の水素生成組成物は、紫外線損傷、放射性療法副作用、神経疾患等を改善できる効果を有することが示された。また、本願の各組合の履き心地は、いずれも市販パックよりいい。そして、同時に過酸化物、水酸化物、固体酸を有する場合は、より最も好ましい疾患の改善効果及び履き心地を達成できた。 As a result, the hydrogen production composition of the present application has an effect of improving ultraviolet damage, radiotherapy side effects, neurological diseases, etc., as compared with a commercially available pack or a set that does not contain aluminum powder (cannot generate hydrogen). Shown. In addition, the comfort of each union of the present application is better than that of a commercially available pack. And, when having a peroxide, a hydroxide, and a solid acid at the same time, a more preferable effect of improving the disease and comfort could be achieved.
表3−パックにおける通気層の各疾患、症状についての改善効果および履き心地 Table 3-Improvement effect and comfort of each disease and symptom of the ventilation layer in the pack
実施例四、創傷被覆材 Example 4, wound dressing
試験の組及び結果を表4に示す。過酸化物は過酸化カリウムであり、水酸化物は水酸化カリウムであり、いずれも2.5gである。アルミニウム粉末は2.5gであり、固体酸であるフィチン酸は適量である。創傷被覆材は水分を吸収することによって、水素を生成した。より水分を保持し、逆方向に傷口に排出しないようにできた。当該通気層のガスだけを流通する設計によって、水素を供給すると同時に傷口が二次感染を避けるという改良効果を得た。 Table 4 shows the test sets and results. The peroxide is potassium peroxide, and the hydroxide is potassium hydroxide, both of which weigh 2.5 g. The amount of aluminum powder is 2.5 g, and the amount of phytic acid, which is a solid acid, is appropriate. The wound dressing produced hydrogen by absorbing water. It was able to retain more water and prevent it from draining into the wound in the opposite direction. By designing to circulate only the gas of the ventilation layer, the improvement effect of supplying hydrogen and at the same time avoiding secondary infection of the wound was obtained.
結果では、市販創傷被覆材、または、アルミニウム粉末を含まない(水素を生成できない)組と比べ、本願の水素生成組成物は、紫外線損傷、放射性療法副作用、創傷治癒等を改善できる効果を有することが示された。また、本願の各組み合わせの履き心地はいずれも市販被覆材よりいい。そして、同時に過酸化物、水酸化物、固体酸を有する場合は、より最も好ましい効果及び履き心地を達成できた。 As a result, the hydrogen producing composition of the present application has an effect of improving ultraviolet damage, side effects of radiotherapy, wound healing, etc., as compared with a commercially available wound dressing or a set containing no aluminum powder (which cannot generate hydrogen). It has been shown. In addition, the comfort of each combination of the present application is better than that of commercially available covering materials. And, when having a peroxide, a hydroxide, and a solid acid at the same time, the most preferable effect and comfort could be achieved.
表4−創傷被覆材における通気層の各疾患、症状についての改善効果および履き心地 Table 4-Improvement effect and comfort of each disease and symptom of the ventilation layer in the wound dressing
また、ナプキンなどの特に液体が漏れない需要を持つものを使用する場合では、同時に高分子吸水材(即ち、高吸水性ポリマー)を添加できる。これにより、液体を吸収し、水素を供給すると同時に、液体が逆流し、皮膚の感染、炎症を引き起こすのを避けるというダブル効果を達成する。 Further, when a napkin or the like which has a demand that the liquid does not leak is used, a polymer water absorbing material (that is, a super absorbent polymer) can be added at the same time. This achieves the double effect of absorbing the liquid and supplying hydrogen, while at the same time preventing the liquid from regurgitating, causing skin infections and inflammation.
総合すると、本発明の通気層は、いかなる水素生成組成物の組み合わせでも、生活衛生材料中に応用すると、いずれも神経疾患、放射性療法副作用、便秘、紫外線損傷、目の渋み、目のつらさ、創傷治癒を改善できる。水素の酸化防止効果および常在菌の効果を改善することによって、一気に従来の生活衛生材料制限の機能の範疇を突破できる。酸素だけを生成する(アルミニウム粉末を含まない)組に対して、本願の水素生成組成物の適用は、より優れた、幅広い身体保健効果を達成でき、有利な効果をもたらす。そして、副産物が酸素を生成できることに起因して、市販(ガスを発生する組成物を含まない)のものより、履き心地がよく、蒸し暑い感じがなく、使用上の履き心地が向上する。同時に過酸化物、水酸化物、固体酸を添加する場合では、より最も好ましい疾患、症状の改善及び履き心地の効果を達成できる。 Taken together, the breathable layers of the present invention, when applied in living hygiene materials in any combination of hydrogen-producing compositions, all include neurological disorders, radiotherapy side effects, constipation, UV damage, astringency of the eyes, tightness of the eyes, wounds. Can improve healing. By improving the antioxidant effect of hydrogen and the effect of indigenous bacteria, it is possible to break through the conventional function of restricting living hygiene materials at once. For a set that produces only oxygen (without aluminum powder), the application of the hydrogen producing composition of the present application can achieve a better, broader range of physical health effects, with beneficial effects. And, due to the fact that the by-product can generate oxygen, it is more comfortable to wear, does not feel hot and humid, and is more comfortable to use than the commercially available one (which does not contain a composition that generates gas). When peroxides, hydroxides and solid acids are added at the same time, the most preferable effects of disease and symptom improvement and comfort can be achieved.
総合すると、本願は短時間で、大量の水素を生成し、人体皮膚、鼻孔、口腔、目、または他の触れる人体部位に供給できる。一般的な水素を発生する方法及び器具に対して、タンクパイプライン、製造機またはプラグインが必要ないという利点があり、携帯しやすく、組成物は無害で、皮膚の近くで使用でき、水素の生成が簡単で、有害な副産物が発生しないなどの優れた効果がある。 Taken together, the present application can generate large amounts of hydrogen in a short period of time and supply it to human skin, nostrils, oral cavity, eyes, or other touching human body parts. It has the advantage of not requiring a tank pipeline, manufacturing machine or plug-in over common hydrogen generating methods and appliances, is easy to carry, the composition is harmless, can be used near the skin, and of hydrogen. It is easy to produce and has excellent effects such as no harmful by-products.
なお、水素は、その構造が簡単であることを応用するため、優れた拡散力があり、届く部位に制限がない。水素は、無毒で、人体に優しい安全な還元剤であり、優れた酸化防止効果があり、常在菌を改善するなどの利点から、従来の周知の生活衛生材料の保健用途上に対し、より幅広い、効果向上の利益が得られる。 Since hydrogen has a simple structure, it has excellent diffusive power and there is no limitation on the reachable part. Hydrogen is a non-toxic, safe reducing agent that is kind to the human body, has an excellent antioxidant effect, and has advantages such as improving indigenous bacteria, so it is more suitable for the health use of conventional well-known living hygiene materials. A wide range of benefits for improving effectiveness can be obtained.
本発明に例示される通気層は、水素の酸化防止及び常在菌効果を改善することによって、対応する疾患に応用でき、本願の実施例によって、本願の通気層を合理的に改善でき、前記2つのいずれかの原因に由来する他の疾患(例えば、ガン、化学療法副作用、代謝疾患、免疫疾患、アレルギー、糖尿病、体重のコントロール、結腸炎など)に応用できる。 The breathable layer exemplified in the present invention can be applied to a corresponding disease by improving the antioxidant effect of hydrogen and the effect of indigenous bacteria, and the breathable layer of the present application can be reasonably improved by the examples of the present application. It can be applied to other diseases resulting from any of the two causes (eg, cancer, chemotherapy side effects, metabolic diseases, immune diseases, allergies, diabetes, weight control, colitis, etc.).
水素生成効果を向上させるため、当該水素生成組成物は必要に応じて、さらに高吸水性ポリマー、活性剤または触媒を含んでもよい。なお、当該水素生成組成物に、さらに酸素および活性酸素を発生できる生成単位を添加し、割合の調整を行い、異なる需要に対して必要な効果を達成できる。 In order to improve the hydrogen production effect, the hydrogen production composition may further contain a super absorbent polymer, an activator or a catalyst, if necessary. In addition, a production unit capable of generating oxygen and active oxygen can be further added to the hydrogen production composition to adjust the ratio, and the required effect can be achieved for different demands.
以上、本発明の具体的な実施例について詳しく説明したが、本発明は当該実施例に限定されるものではない。本発明の技術精神を逸脱しない同等な実施または変更であれば、いずれも本願の特許請求の範囲の中に含まれる。 Although specific examples of the present invention have been described in detail above, the present invention is not limited to the examples. Any equivalent practice or modification that does not deviate from the technical spirit of the present invention is included in the claims of the present application.
上記の複数の効果は、実に十分に新規性および進歩性を有する特許要件であるため、法により出願する。貴局より本件発明の特許出願案を許可していただき、これをもって発明を励行致します。 Since the above-mentioned multiple effects are patent requirements that are truly novel and inventive, they are filed by law. Your office will approve the patent application proposal for the present invention, and we will enforce the invention with this.
1 通気層
11 薄層
111 小さい孔
12 水素生成組成物
1
Claims (9)
前記薄層の中に含まれ、漏れることなく空気中の水分または液体の水を吸収して水素を生成する水素生成組成物と、
を含み、
前記水素は、前記複数の小さい孔を通過して、皮膚および人体内部に排出されて供給され、
前記水素生成組成物は、金属過酸化物または金属水酸化物、および、アルミニウム粉末を含み、
前記水素生成組成物の重量割合は、金属過酸化物または金属水酸化物:アルミニウム粉末=1:100−100:1、好ましくは1:10−10:1であり、
前記水素生成組成物は、pHが4−9の間になるように固体酸が添加され、
前記固体酸は、固体クエン酸、固体乳酸、固体シュウ酸、固体塩酸、固体フィチン酸および固体ケイ酸からなる群より選択される、
通気層。 A thin layer that is thin, not ventilated on the outside, ventilated on the inside, has multiple small holes on the inner surface, and is single or multi-layered.
A hydrogen-producing composition contained in the thin layer, which absorbs water in the air or liquid water without leaking to generate hydrogen.
Including
The hydrogen passes through the plurality of small holes and is discharged and supplied into the skin and the human body.
The hydrogen production composition contains a metal peroxide or a metal hydroxide, and an aluminum powder.
Weight ratio of said hydrogen product composition, metal peroxides or metal hydroxide: aluminum powder = 1: 100-100: 1, preferably 1: 10-10: Ri 1 der,
The hydrogen production composition is added with a solid acid so that the pH is between 4-9.
The solid acid is selected from the group consisting of solid citric acid, solid lactic acid, solid oxalic acid, solid hydrochloric acid, solid phytic acid and solid silicic acid.
Ventilation layer.
請求項1に記載の通気層。 The material inside the thin layer is silica gel, non-woven fabric, or plastic breathable membrane.
The ventilation layer according to claim 1.
請求項1に記載の通気層。 The outer material of the thin layer is polypropylene, polyethylene plastic thin film, or aluminum film.
The ventilation layer according to claim 1.
請求項1に記載の通気層。 The hydrogen production composition is in the form of powder or pellets.
The ventilation layer according to claim 1.
請求項1に記載の通気層。 The metal peroxide is selected from the group consisting of calcium peroxide, magnesium peroxide, sodium peroxide, and potassium peroxide.
The ventilation layer according to claim 1.
請求項1に記載の通気層。 The metal hydroxide is selected from the group consisting of calcium hydroxide, magnesium hydroxide, sodium hydroxide, and potassium hydroxide.
The ventilation layer according to claim 1.
請求項1に記載の通気層。 The hydrogen production composition further comprises a super absorbent polymer, or a catalyst.
The ventilation layer according to claim 1.
請求項1に記載の通気層。 The thin layer further contains oxygen and reactive oxygen species.
The ventilation layer according to claim 1.
前記生活衛生材料は、アイマスク、口マスク、顔マスク、パック、ブラジャー、ニプレス、胸部パッド、ナプキン、紙おむつ、サニタリーパッド、創傷被覆材、絆創膏、ガーゼ、および痔疾用パッドを含む、
請求項1に記載の通気層。 The ventilation layer can be used in living hygiene materials
The living hygiene materials include eye masks, mouth masks, face masks, packs, bras, pasties, chest pads, napkins, paper diapers, sanitary pads, wound dressings, adhesive plasters, gauze, and hemorrhoid pads.
The ventilation layer according to claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019039635A JP6814239B2 (en) | 2019-03-05 | 2019-03-05 | Ventilation layer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019039635A JP6814239B2 (en) | 2019-03-05 | 2019-03-05 | Ventilation layer |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020143005A JP2020143005A (en) | 2020-09-10 |
JP6814239B2 true JP6814239B2 (en) | 2021-01-13 |
Family
ID=72353206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019039635A Active JP6814239B2 (en) | 2019-03-05 | 2019-03-05 | Ventilation layer |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6814239B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6883133B1 (en) * | 2020-05-07 | 2021-06-09 | ティーオーツーエム コーポレーション | Gas supply mask |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6046936B2 (en) * | 2012-07-23 | 2016-12-21 | クラシエホームプロダクツ株式会社 | Hydrogen generating cloth, hydrogen generating paper, and production method thereof |
JP2014084233A (en) * | 2012-10-19 | 2014-05-12 | Seiji Endo | Dry sheet for generating hydrogen |
JP2015167840A (en) * | 2014-03-11 | 2015-09-28 | ナチュラン・インターナショナル有限会社 | Sanitary article |
JP2016137010A (en) * | 2015-01-26 | 2016-08-04 | 幸信 森 | Storage container of hydrogen-containing cosmetics |
JP6726433B2 (en) * | 2016-05-24 | 2020-07-22 | 東洋アルミニウム株式会社 | Face pack and combination structure of the face pack and face pack serum |
WO2018037818A1 (en) * | 2016-08-23 | 2018-03-01 | 小林 光 | Hydrogen supply material and production method therefor, and hydrogen supply method |
JP2018099645A (en) * | 2016-12-20 | 2018-06-28 | ロート製薬株式会社 | Gas injection tool, manufacturing method of gas injection tool, and gas injection tool assembly kit |
JP6844837B2 (en) * | 2016-12-28 | 2021-03-17 | フェリック株式会社 | Hydrogen generation composition |
JP2018130712A (en) * | 2017-02-13 | 2018-08-23 | エコモ・インターナショナル株式会社 | Hydrogen generating agent using hydrate compound |
JP3218013U (en) * | 2018-07-05 | 2018-09-13 | ゲィリー ツァワーGarry Tsaur | Skin care mask |
-
2019
- 2019-03-05 JP JP2019039635A patent/JP6814239B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2020143005A (en) | 2020-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI720465B (en) | Micro-environment hydrogen supply gas permeable layer and its use | |
CN111481425A (en) | Microenvironment hydrogen supply breathable layer and external application bag | |
KR200493176Y1 (en) | Hygiene product | |
TWM583850U (en) | Microenvironment hydrogen supply gas-permeable layer and use thereof | |
CN101999759B (en) | Herbal health protection bra pad | |
US11471423B2 (en) | Microenvironmental gas permeable layer capable of supplying hydrogen | |
JP2019194162A (en) | Ventilation material comprising whitening and heating function by oxygen supply to skin | |
JP6814239B2 (en) | Ventilation layer | |
US10695456B2 (en) | Skin-friendly absorbent structure for providing oxygen | |
CN105662727A (en) | Far-infrared negative oxygen ion sanitary towel | |
WO2020151005A1 (en) | Breathable layer for microenvironment hydrogen supply | |
TWM592306U (en) | Multilayer device for supplying nitric oxide | |
CN204812203U (en) | Medical surgery gauze mask | |
CN211797230U (en) | Multilayer device for supplying nitric oxide | |
TWI750362B (en) | Breathable material with skin whitening, oxygen supply and heating function | |
CN212522757U (en) | Air supply port cover | |
JP3207724U (en) | Hygiene products | |
TW201730100A (en) | A composition capable of fast locally producing oxygen which uses the peroxide as the oxygen-supplying source, which is selected from groups of the peroxide and superoxide | |
TWI816904B (en) | A multi-layer device for supplying nitric oxide | |
CN209450911U (en) | A kind of ear nose filling type device improved and prevent the infection of the upper respiratory tract | |
CN201996744U (en) | Nursing healthcare type sanitary towel for women | |
CN201768084U (en) | Bamboo charcoal and bamboo fiber disposable sanitary towel | |
CN206934253U (en) | Medical nursing pad | |
KR102213117B1 (en) | Hydrogen patch | |
WO2021068134A1 (en) | Multilayer device for supplying nitric oxide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190305 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191224 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200323 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200714 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201009 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20201020 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20201020 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20201201 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20201218 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6814239 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |